BetterLife Pharma Inc.
BETR
CNSX
10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 13.40K | 91.40K | 307.70K | 27.90K | 66.70K |
Total Receivables | 5.30K | 18.10K | 16.30K | 29.60K | 9.20K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 176.10K | 216.00K | 252.70K | 185.20K | 290.90K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 194.70K | 325.60K | 576.60K | 242.70K | 366.90K |
|
|||||
Total Current Assets | 194.70K | 325.60K | 576.60K | 242.70K | 366.90K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 194.70K | 325.60K | 576.60K | 242.70K | 366.90K |
|
|||||
Total Accounts Payable | 3.09M | 3.05M | 2.95M | 3.32M | 3.84M |
Total Accrued Expenses | 635.80K | 871.80K | 1.10M | 1.20M | 690.80K |
Short-term Debt | 167.40K | 167.60K | 185.50K | 171.70K | 57.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 34.30K | 20.70K | -- | -- | -- |
Total Finance Division Other Current Liabilities | 289.00K | 421.40K | 400.70K | 414.70K | 9.00K |
Total Other Current Liabilities | 289.00K | 421.40K | 400.70K | 414.70K | 9.00K |
Total Current Liabilities | 4.21M | 4.53M | 4.64M | 5.10M | 4.59M |
|
|||||
Total Current Liabilities | 4.21M | 4.53M | 4.64M | 5.10M | 4.59M |
Long-Term Debt | 580.50K | 560.50K | 902.10K | 245.00K | -- |
Short-term Debt | 167.40K | 167.60K | 185.50K | 171.70K | 57.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 169.90K | 715.80K | 692.30K | 647.20K | 580.10K |
Total Liabilities | 4.96M | 5.81M | 6.23M | 5.99M | 5.17M |
|
|||||
Common Stock & APIC | 57.28M | 57.79M | 57.10M | 58.64M | 56.40M |
Retained Earnings | -84.58M | -85.76M | -85.14M | -86.01M | -81.92M |
Treasury Stock & Other | 20.13M | 20.10M | 20.18M | 19.29M | 18.90M |
Total Common Equity | -7.17M | -7.87M | -7.86M | -8.08M | -6.61M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -7.17M | -7.87M | -7.86M | -8.08M | -6.61M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 2.40M | 2.39M | 2.20M | 2.33M | 1.80M |
Total Equity | -4.77M | -5.48M | -5.66M | -5.75M | -4.81M |
|